AFT Pharmaceuticals

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.

Company Details

Registered Office: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622

Postal Address: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622

Telephone: +64 9 488 0232

Facsimile: n/a

Website: www.aftpharm.com

First Listed: 22/12/2015

Balance Date: 31 March

AGM: 04/08/2023

Directors and Executives

Hartley Atkinson

Executive Director

Marree Atkinson

Executive Director

Anita Baldauf

Independent Director

David Flacks

Chairman

Andrew Lane

Director

Malcolm Tubby

CFO / Company Secretary

Ted Witek

Independent Non-Executive Director

Announcements

Title	Date	Type
June Quarter FY 2026 Investor Update	Tue, Jul 01 2025 08:35 am	GENERAL
Disclosure of Directors and Senior Managers Relevant Intere	Fri, Jun 27 2025 08:42 am	SHINTR
Notice of Annual Meeting of Shareholders 2025	Fri, Jun 27 2025 08:39 am	MEETING
Annual Meeting and Closing Date for Director Nominations	Fri, May 30 2025 08:59 am	MEETING
AFT and Hikma extend US Maxigesic Cooperation	Mon, May 26 2025 08:38 am	GENERAL
Corrected Distribution Notice	Thu, May 22 2025 12:18 pm	CORPACT
AFT sees strong FY 26 as revenue reaches new record	Thu, May 22 2025 08:30 am	FLLYR
AFT to announce full year results on Thursday May 22 2025	Thu, May 01 2025 08:48 am	GENERAL
March investor update	Mon, Mar 31 2025 10:03 am	GENERAL
ASX Small Cap presentation 250326	Wed, Mar 26 2025 08:50 am	GENERAL

Major Holdings Announcements

Date	Name	No. Held	%	Current
16/09/20	Forsyth Barr Group Limited and Fors	1,617,818	71.25	1.55
15/06/20	Hartley Campbell Atkinson and Colin	72,031,609	72.60	69.82
15/06/20	The CRG Persons	-	15.99	-
25/05/17	AFT Pharmaceuticals Limited	-	72.34	-

Director’s Interests Announcements

Date	Name	No. Held	%	Details	Other
18/09/23	Jon Lamb	271,314	-	-	-
14/04/21	Malcolm Tubby	143,892	-	-	-
10/08/20	Hartley Atkinson	72,899,435	-	-	-
03/07/20	David Flacks	178,764	-	-	-
22/08/18	James Burns	125,417	-	-	-
19/06/17	John Douglas Wilson	56,689	-	-	-

Analysts’ Forecasts

	profit2021	profit2022	eps2021	dps2021	sales2021	ebit2021	ebitda2021
mean	13.7	13.1	2.0	191.3	22.0	24.6
high	13.7	13.1	2.0	191.3	22.0	24.6
low	13.7	13.1	2.0	191.3	22.0	24.6
sample	1	0	1	1	1	1	1

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.

Last Updated: 04/07/2023